Anaylsing the financials the cash flow is receding (, trade debtors are reduced from last year and revenue is not increasing , the delaying of projects is still killing the profit. Net assets have increased and financial libilities are down but do note the increase of intangables which is basically creative accounting (estimates are used in replacement of m/v). So looking at the decreasing c/f, either there is bad management of projects or a lot in the pipeline which payment has not been received. Being optimistic as long as contracts keep coming in and the projects are getting back on track a return to profit next year is pretty much certain.
- Forums
- ASX - By Stock
- silence
Anaylsing the financials the cash flow is receding (, trade...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WDS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$25.36 |
Change
0.310(1.24%) |
Mkt cap ! $46.70B |
Open | High | Low | Value | Volume |
$25.14 | $25.50 | $25.11 | $207.5M | 8.180M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3198 | $25.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$25.36 | 140846 | 6 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
WDS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online